Editorial and Publishing Policies

Authorship Responsibilities
Corresponding Authorship Responsibilities
Open Access Policy
Archiving in PubMed Central
Duplicate Publication
Competing Interest Policy For Authors
Competing Interest Policy For Reviewers
Confidentiality and Publicity Policy
Research Materials Availability
Correction and Retraction Policy
Publication Costs
Fee Assistance

Authorship Responsibilities
Regenerative Biology does not require all of the authors on a manuscript to sign the submission letter. Submission of the manuscript is performed by the corresponding author, and it is their onus to ensure before submission that all of the listed authors have consented to the entirety of the manuscript: text, data, claims, order of author list, and contribution statements. During the editorial process, the corresponding author functions as the laison between the editorial board and listed authors such that agreements are reached with the consent of all authors. Any corrections after publication, require the signed approval of every author (see Correction and Retraction Policy).
Authorship denotes a researcher’s contribution to the research or manuscript and all authors are to include a statement of their contributions to the research. Criteria for authorship may include: concept and project design, data acquisition, data interpretation, manuscript drafting, final approval and accountability for the published work.
Regenerative Biology assumes that the corresponding author, or the most senior author, has accepted responsibility for the manuscript on behalf of all the authors. Responsibilities include, but not are not limited to: 1) ensuring the integrity of the data is preserved from the time of submission and can be recalled for verification, should it be necessary; 2) approving that the submitted data is representative of the original research and has not been altered or fabricated to misrepresent the work.
Authors who had an equal contribution to the work can be specified as such in the authors information section.

Corresponding Author Responsibilities
The corresponding author is held solely responsible for managing communications with the journal, and as the interlocutor among the authors and the journal. Prior to submission, the corresponding author ensures that all authors are on the author list, that the order and appropriate credit is granted to each author, and that all authors are in agreement for submission of the manuscript.
The corresponding author signs electronically an Author Statements on behalf of all the authors, as part of the online submission system regarding the original research. However, upon acceptance, a signed copy of the Author Statements with signatures from all authors on the paper is required before publication. Any previously published material included in the manuscript from other authors must be credited and receive written consent from the authors/publishers.
It is the responsibility of the corresponding author to provide all authors on the author list with a copy of the final revised manuscript and interact with the journal to reach an agreement from all authors. The accuracy of the content, author information and final editing is also the  responsibility of the corresponding author.
The corresponding author is the authorized point of contact and inquiries regarding the published material will occur through correspondence with the corresponding author. It is the corresponding author’s responsibilities to alert other listed authors of any arising matters.
Authors should alert Regenerative Biology to any errata that necessitates correction. Any corrections made in published material requires written consent from all authors and should be coordinated by the corresponding author.

Open Access Policy
open access
This journal provides open access to all content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Such access is associated with increased readership, a greater transparency, and increased citation of an author’s work. Under the Creative Commons public domain license (CC-BY), authors retain copyright of their published work. However, anyone may download, distribute, develop, or reuse as long as due credit is provided to the original authors and source of work.

Archiving in PubMed Central
As part of open access and greater visibility of scientific research, Regenerative Biology will deposit all publications into PubMed Central. PubMed Central is a public archive created by the National Center for Biotechnology Information of the National Library of Medicine in the United States; a free government repository for published scientific literature.

We deem plagiarism of any text, data, or ideas as one’s own without proper acknowledgement to the original author, as plagiarism. Plagiarism in any form is not allowed at Regenerative Biology. Authors found of such actions will not be allowed to publish their submitted or future work in Regenerative Biology. Submissions are verified with CrossCheck for integrity of the submitted manuscripts. In cases of suspected plagiarism, Regenerative Biology will take action according to the Committee on Publication Ethics (COPE).

Duplicate Publication
Submitted manuscripts that utilize a substantial amount of the authors’ previously published work without citing it, is deemed a duplicate publication. In other cases, very closely related manuscripts will have been submitted to another journal for publication review. Upon submission, authors are required to confirm that the manuscript, or a manuscript on closely related work, has not been submitted, accepted, or under review elsewhere. If the authors have submitted a closely related work elsewhere, authors must attach a copy upon submission for the editors and reviewers consideration. If we discover that a duplicate publication from the author was published elsewhere, previous to a publication in Regenerative Biology, we will issue a formal retraction and authors will be precluded from future publications in the journal.

Competing Interest Policy For Authors
To ensure transparency in research, the corresponding author must declare all competing interests of all the authors, upon manuscript submission. A statement of competing interests will be published at the end of the article:

  • The authors declare competing financial interests
  • The authors declare no competing interests.

In the case of competing interest, the authors are to include a brief description at the end of their submitted manuscript.

Competing interests may include, but are not limited to:

  • any research support including direct financial aid, laboratory supplies, or other,  from an organization that may be financially affected by the publication
  • personal financial gain
  • patent applications
  • paid employment or consultancy
  • gifts

Under some confidentiality and nondisclosure agreements, authors may be prohibited from publicly disclosing their competing interests. In such cases, editors will investigate and may choose an alternate disclosure as they deem fit.

Competing Interest Policy For Reviewers
Editors and reviewers must have declare a statement of no competing interests prior to handling any submitted manuscript. If there are competing interest, alternate editors or reviewers will be chosen.

Confidentiality and  Publicity Policy
All details of a submitted manuscript are kept confidential and any editor or reviewer whom handles the manuscript is required to sign a confidentially agreement. The agreement prohibits editors and reviewers from relaying any information regarding the submitted manuscript, supplementary data or editorial evaluation to any persons outside of Regenerative Biology before publication. The reviewers comments and other confidential documents may not be publicly shared (website, public posting) without prior consent from Regenerative Biology editors. Authors may not pre-publicize to the media their publication during the editorial process and before publication.

Research Materials Availability
The goal of scientific publications is for researchers to add to our current scientific understanding and advance the field. However, the majority of published articles in top journals can not be replicated, some times even in the same lab where the original work was performed.  Regenerative Biology encourages our editors to critically examine the experimental methods and hold authors to a high standard of transparency in their experimental protocols.  Publication is contingent upon the authors agreement to make freely available all materials and methods in the article and supporting data. Upon submission, the authors are to include all supporting data to allow editors and reviewers to make a more informed decision. In some cases, additional information regarding specific protocols will be required, and which the authors are to disclose for review. Non-compliance with Regenerative Biology’s policy on sharing materials may result in a refusal of publication. Any restrictions on the availability of any materials, especially pertaining to the use of private material and therefore not available for public dissemination, should be noted in the submission. Readers should immediately notify Regenerative Biology if they have difficulty obtaining materials from an author. After publication, if an author is discovered to be withholding materials from the scientific community, Regenerative Biology will take appropriate action.
It is the author’s onus to ensure that their materials and data can be shared with the public. Large data sets can often be deposited in public repositories or hosted at the author’s institutional website for public access. We encourage authors to deposit DNA constructs into repositories such as Addgene, to help alleviate the task of filling requests. For cell lines, there are a number of repositories such as the American Type Culture Collection (ATCC) and the RIKEN Bioresource Center.

Correction and Retraction Policy
We believe the best form of ensuring scientific integrity is policing by scientific peers. We encourage rebuttals from our readers on published research articles. Editors will review the rebuttal on the grounds of its scientific argument and determine if it merits peer review. Rebuttals passing the peer review process will be published in the Correspondence section and linked to the original article. The rebuttal may include a response from the author of the original article, if they choose to submit one. Any concerns on non-research articles should be addressed to the editor.

Types of corrections:

Corrigendum – Notification of errors made by the author(s) which affects the scientific integrity of the published findings or the journal name. All Authors must sign the document with the listed corrigenda declaring that they sanction all corrections listed. In the case where author(s) refuse to issue corrections,or there are some authors whom do not agree to the corrections, Editors with the aid of peer-reviewers, will take appropriate action (corrigendum and listing of dissenters or a retraction).

Erratum –  Notification of errors made by the journal which affects the scientific integrity of the published findings or the journal name

Retraction – Notification of irreproducible or falsified results. The corresponding author coordinates a formal letter of retraction, signed by all authors, with descriptions detailing the errors that lead to the article’s conclusions. In the case where author(s) disagree on retraction status, editors with the aid of peer-reviewers, will take appropriate action (retraction and  listing of dissenters).

Addendum – Notification of additional peer-reviewed information to a publication.

The correct abbreviation for abstracting and indexing is Regen. Bio.

The international standard serial number for Regenerative Biology is 1553-6157.

To provide Open Access, Regenerative Biology charges an article processing fee of $2500. Articles solicited by Regenerative Biology editors have no publication costs.

We believe that publishing fees should never be a barrier to Open Access publications. Authors who come from developing countries or who are unable to meet publication fees, can apply for a publication fee waiver through our Science Freedom Initiative.